BPA Call HT001415A0010-HT001419F0371
Award Date 9/10/19
Potential Completion Date 9/9/20
Potential Value $98K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20889, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The award, with a ceiling value of $302,000.00, is a Blanket Purchase Agreement (BPA) Call placed by the Defense Health Agency (DHA) for the procurement of REAGENTS AND CONSUMABLES. This BPA is part of a larger Indefinite Delivery Contract vehicle held by Roche Diagnostics to provide chemistry reagents...
- The U.S. Defense Health Agency awarded Roche Diagnostics Corporation a Blanket Purchase Agreement (BPA) call valued at $2,515,000.00 for the provision of reagents and consumables. This is not a set-aside contract. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics, has provided critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services to various federal agencies, including the Department of Veterans Affairs, Department of...
- The Defense Health Agency has awarded a Blanket Purchase Agreement (BPA) call to Roche Diagnostics Corporation, a global manufacturer of in vitro diagnostic products and laboratory equipment, for the provision of reagents and consumables. This contract is a child award under the VA Schedule V797P-7347A and carries a ceiling value of $288,642.16 under firm fixed-price terms. The award was made on April 30, 2025, with an ultimate completion date of May 2, 2025, and no set-aside designation was...
- This is a Blanket Purchase Agreement (BPA) call awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $3,330,384.44, is for the provision of reagents and peripherals with a firm fixed price pricing type. The contract does not have a set-aside designation, indicating Roche Diagnostics competed openly in the...
- This is a firm-fixed-price BPA call contract awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract, valued at up to $100,000.00, is for the provision of reagents and supplies used for chemistry testing. The contract has no set-aside designation. Roche Diagnostics holds several Indefinite Delivery Contracts (IDCs) and Blanket...
- The Defense Health Agency awarded a Blanket Purchase Agreement (BPA) call to Roche Diagnostics Corporation for reagents for testing, with a ceiling value of $24,331.14 and a firm fixed price structure. The contract was awarded on October 8, 2025, with an ultimate completion date of September 30, 2026, and will be performed in Castleton, Indiana. This award represents a child contract under a larger vehicle, leveraging Roche Diagnostics' established GSA Schedule contracts for in vitro diagnostics...
- This is a federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the provision of reagents and peripheral supplies. The contract was awarded by the Defense Health Agency, is a Blanket Purchase Agreement (BPA) Call with a firm fixed price, and has a potential value of $2,238,187.65. The contract has no set-aside designation. Roche Diagnostics is a foreign-owned, for-profit organization that manufactures in vitro diagnostics, reagents, laboratory...
- This is a Blanket Purchase Agreement (BPA) call awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract is for REAGENTS AND SUPPLIES with a ceiling value of $59,787.69 and an ultimate completion date of September 30, 2019. This BPA call is part of a larger $37 million BPA with DHA for immunochemistry and clinical...
- This is a firm fixed-price BPA call order awarded by the Defense Health Agency to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for reagents and peripheral supplies for the pathology department. The contract, worth $99,999.80, has an ultimate completion date of September 30, 2019. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. This award is not set aside and is...
- The Defense Health Agency (DOD) awarded Roche Diagnostics Corporation a $1,534,292.82 firm fixed price blanket purchase agreement (BPA) call contract to provide reagents and supplies. The contract has a period of performance from January 21, 2022 through July 1, 2022 and will be performed in Bethesda, Maryland. Roche Diagnostics Corporation will serve as the prime contractor to supply laboratory reagents and consumable materials to the Defense Health Agency in support of their medical testing...